Skip to main content

News

A member of staff using the equipment

Study reveals insights on timing of Huntington’s Disease onset

8 August 2019

New research results challenge an accepted theory about the timing of Huntington’s disease.

Summer school 2019

10th annual MRC Summer School welcomes delegates from far and wide

15 July 2019

Attendees travelled from all over the world for an introduction to brain disorder research.

School children taking part in DNA extraction activity

MRC festival of medical research

24 June 2019

We celebrated this year's MRC Festival of Medical Research by inviting school children to learn more about genetics, mental health and our research.

Dr Emma Tallantyre

International multi-centre collaboration to investigate treatment approaches in multiple sclerosis

1 June 2019

Investigating two different treatment approaches in MS

Genetic fingerprint

Global study identifies genetic risk factors linked to bipolar disorder

9 May 2019

A global team of researchers have identified 30 areas of the human genome where variations in genetic code can increase the risk of developing bipolar disorder.

artist's image of DNA

Genetic conditions lead to range of overlapping needs in children

3 May 2019

New study reveals extent of developmental difficulties caused by deletions and duplications of DNA

Kim Kendall

Rare genetic changes associated with increased risk of depression

24 April 2019

A study at Cardiff University has found a link between rare changes in our genetic code and the increased likelihood of developing depression.

fatigue MS

Study uncovers predictors of fatigue in multiple sclerosis

1 April 2019

Study found that it was largely related to indirect psychological factors

DNA image

New insights into underlying causes of Alzheimer’s disease

28 February 2019

Cardiff University’s largest-ever Alzheimer’s gene study achieves landmark breakthroughs

Pharmacist with boxes of pills

Improved outlook for people of African descent with treatment-resistant schizophrenia

26 February 2019

More people of African descent with treatment-resistant schizophrenia could be safely given drug best proven to manage symptoms